公开(公告)号：US08696817B2

公开(公告)日：2014-04-15

申请号：US10579374

申请日：2004-11-26

申请人： Peter Nord ,  Rolf Andersson

发明人： Peter Nord ,  Rolf Andersson

IPC分类号： B08B7/00

CPC分类号： C25C7/08

摘要： The invention relates to an equipment for removing deposits accumulated in electrolytic refining on the surface of an electrode, such as a cathode, said equipment including at least one element for stripping the deposits and at least one element for controlling the stripping element; said equipment includes at least one stripping element that is turnably movable in the vertical direction of the cathode, and the cathode can be bent owing to the contact with said stripping element. The invention also relates to a method realized by said equipment.

摘要翻译： 本发明涉及一种用于去除在诸如阴极的电极的表面上积聚在电解精炼中的沉积物的设备，所述设备包括用于剥离沉积物的至少一个元件和用于控制剥离元件的至少一个元件; 所述设备包括可在阴极的垂直方向上可转动地移动的至少一个剥离元件，并且阴极可由于与所述剥离元件的接触而弯曲。 本发明还涉及由所述设备实现的方法。

公开(公告)号：US20080006575A1

公开(公告)日：2008-01-10

申请号：US11569570

申请日：2005-05-23

申请人： Jan Berntsson ,  Mikkael Dahlen ,  Rolf Andersson

发明人： Jan Berntsson ,  Mikkael Dahlen ,  Rolf Andersson

IPC分类号： B01D46/12 ,  B01D46/52 ,  B01D53/18

CPC分类号： B01D46/523 ,  B01D46/003 ,  B01D46/10

摘要： In a filter unit with a folded filter mat that has spacing devices between parallel opposing parts of the filter mat, the contaminants (e.g. liquids) that have been filtered out collect at the bottom of the unit. The air flowing through the unit is capable of sucking up contaminant liquids so that the air leaving the unit, rather than being clean, contains undesirable, previously filtered contaminants. The present invention reduces such additional contamination by so designing/arranging the spacing devices that they prevent additional contamination being added to the air flowing through the filter unit.

摘要翻译： 在具有折叠过滤垫的过滤器单元中，其在过滤垫的平行相对部分之间具有间隔装置，已经过滤掉的污染物（例如液体）在单元的底部收集。 流经单元的空气能够吸入污染液体，使得离开单元的空气而不是清洁的空气含有不期望的先前过滤的污染物。 本发明通过设计/布置间隔装置来减少这种附加的污染，从而防止了额外的污染物被附加到流过过滤器单元的空气中。

公开(公告)号：US4019675A

公开(公告)日：1977-04-26

申请号：US624411

申请日：1975-10-21

申请人： Rolf Andersson ,  Bengt Bjorklund ,  Tommy Hedberg

发明人： Rolf Andersson ,  Bengt Bjorklund ,  Tommy Hedberg

IPC分类号： B65D5/20 ,  B65D5/24 ,  B65D5/44 ,  B65D5/64 ,  B65D43/02 ,  B65D5/12

CPC分类号： B65D5/246 ,  B65D43/021 ,  B65D5/2047 ,  B65D5/44 ,  B65D5/445 ,  B65D2543/00194 ,  B65D2543/00296 ,  B65D2543/00509 ,  B65D2543/00546 ,  B65D2543/00648 ,  B65D2543/00685 ,  B65D2543/00731 ,  B65D2543/00796 ,  B65D2543/00842

摘要： A locking container is disclosed which comprises a bottom wall and at least one wall projecting upwardly from the bottom wall so as to define a cavity. The container further includes a flange projecting outwardly from the wall and provided with reinforcing means secured thereto which extend inwardly from the wall into the cavity. The reinforcing means are adapted to receive and lock in place a cover member in sealing relationship to the container.

摘要翻译： 公开了一种锁定容器，其包括底壁和从底壁向上突出以限定空腔的至少一个壁。 容器还包括从壁向外突出的凸缘，并且设置有固定到其上的加强装置，其从壁向内延伸到空腔中。 加强装置适于接收和锁定与容器密封关系的盖构件。

公开(公告)号：US20120101066A1

公开(公告)日：2012-04-26

申请号：US13379468

申请日：2010-07-06

申请人： Jan-Olof Karlsson ,  Rolf Andersson

发明人： Jan-Olof Karlsson ,  Rolf Andersson

IPC分类号： A61K31/675 ,  A61K31/444 ,  A61K31/506

摘要： A pharmaceutical composition for treatment of a pathological condition in a patient comprises, as a first component, a manganese complex of Formula I( ), and, as a second component, a non-manganese complex compound of Formula (I), optionally together with one or more physiologically acceptable carriers and/or excipients, wherein X, R, R, R, and R are as defined herein. Methods for treatment of a pathological condition in a patient, for example, a pathological condition caused by the presence of oxygen-derived free radicals, comprises administering to said patient the first component and the second component.

摘要翻译： 用于治疗患者病理状况的药物组合物包含作为第一组分的式I（）的锰络合物，作为第二组分的式（I）的非锰络合物，任选与 一种或多种生理上可接受的载体和/或赋形剂，其中X，R，R，R和R如本文所定义。 用于治疗患者病理状况的方法，例如由存在氧源自由基导致的病理状况，包括向所述患者施用第一组分和第二组分。

公开(公告)号：US06299387B1

公开(公告)日：2001-10-09

申请号：US09603149

申请日：2000-06-23

申请人： Rolf Andersson

发明人： Rolf Andersson

IPC分类号： B65G5100

CPC分类号： B65D88/28 ,  B65D88/72

摘要： A conveyor comprises perforation bands arranged in the floor of a storage space. Some of the bands emit an air stream that in quantity or pressure differs from the air stream in the remaining bands and have apertures with a larger flow area than the apertures in the remaining bands. The larger apertures are provided: along with a first perforation band placed in the middle of a sector of the floor and extending across the entire sector; along one further band arranged on one side of the first band with a shorter extension than in the first band; and in portions of bands which portions are closest to the walls of the storage space.

摘要翻译： 输送机包括布置在存储空间的地板中的穿孔带。 一些带发出空气流，其数量或压力与其余带中的气流不同，并且具有比其余带中的孔更大的流动面积的孔。 提供较大的孔口：连同位于地板的扇形区域的中间并延伸穿过整个扇区的第一穿孔带; 沿着在第一带的一侧上布置有比在第一带中更短的延伸的另一个带; 并且在部分最靠近存储空间的壁的部分中。

公开(公告)号：US10688087B2

公开(公告)日：2020-06-23

申请号：US13379468

申请日：2010-07-06

申请人： Jan-Olof Karlsson ,  Rolf Andersson

发明人： Jan-Olof Karlsson ,  Rolf Andersson

IPC分类号： A61K31/444 ,  A61K31/506 ,  A61K33/32 ,  A61K45/06

摘要： A pharmaceutical composition for treatment of a pathological condition in a patient comprises, as a first component, a manganese complex of Formula I( ), and, as a second component, a non-manganese complex compound of Formula (I), optionally together with one or more physiologically acceptable carriers and/or excipients, wherein X, R, R, R, and R are as defined herein. Methods for treatment of a pathological condition in a patient, for example, a pathological condition caused by the presence of oxygen-derived free radicals, comprises administering to said patient the first component and the second component.

公开(公告)号：US08377969B2

公开(公告)日：2013-02-19

申请号：US12808144

申请日：2008-12-12

申请人： Jan Olof G. Karlsson ,  Tino Kurz ,  Rolf Andersson

发明人： Jan Olof G. Karlsson ,  Tino Kurz ,  Rolf Andersson

IPC分类号： A61K31/444 ,  A61K31/506

CPC分类号： A61K31/444 ,  A61K31/44 ,  A61K31/675

摘要： Compound of Formula I or a salt thereof for treating cancer, wherein X represents CH or N; R1 represents hydrogen or —CH2COR5; R5 represents hydroxy, optionally hydroxylated alkoxy, amino or alkylamido; R2 represents ZYR6; Z represents a bond, or a C1-3 alkylene or oxoalkylene group optionally substituted by R7; Y represents a bond, an oxygen atom or NR6; R6 is a hydrogen atom, COOR8, an alkyl, alkenyl, cycloalkyl, aryl or aralkyl group optionally substituted by one or more selected from COOR8, CONR82, NR82, OR8, ═NR8, ═O, OP(O)(OR8)R7 and OSO3M; R7 is hydroxy, an optionally hydroxylated, optionally alkoxylated alkyl or aminoalkyl group; R8 is a hydrogen atom or an optionally hydroxylated, optionally alkoxylated alkyl group; M is a hydrogen atom or one equivalent of a physiologically tolerable cation; R3 represents C1-8 alkylene, 1,2-cykloalkylene, or 1,2-arylene, optionally substituted with R7; and R4 represents hydrogen or C1-3 alkyl.

摘要翻译： 式I化合物或其盐用于治疗癌症，其中X表示CH或N; R1表示氢或-CH2COR5; R5表示羟基，任选羟基化的烷氧基，氨基或烷基酰氨基; R2表示ZYR6; Z表示键或任选被R 7取代的C 1-3亚烷基或氧代亚烷基; Y表示键，氧原子或NR 6; R6是氢原子，COOR8，烷基，烯基，环烷基，芳基或芳烷基，任选被一个或多个选自COOR8，CONR82，NR82，OR8，... NR8，= O，OP（O）（OR8）R7和 OSO3M; R7是羟基，任选羟基化，任选烷氧基化的烷基或氨基烷基; R8是氢原子或任选羟基化，任选烷氧基化的烷基; M是氢原子或1当量的生理上可耐受的阳离子; R 3表示任选被R 7取代的C 1-8亚烷基，1,2-亚环烷基或1,2-亚芳基; 并且R 4表示氢或C 1-3烷基。

公开(公告)号：US20100298271A1

公开(公告)日：2010-11-25

申请号：US12808144

申请日：2008-12-12

申请人： Jan Olof G. Karlsson ,  Tino Kurz ,  Rolf Andersson

发明人： Jan Olof G. Karlsson ,  Tino Kurz ,  Rolf Andersson

IPC分类号： A61K31/675 ,  C07F9/58 ,  C07D401/12 ,  A61K31/4415 ,  A61P35/00

CPC分类号： A61K31/444 ,  A61K31/44 ,  A61K31/675

摘要： Compound of Formula I or a salt thereof for treating cancer, wherein X represents CH or N; R1 represents hydrogen or —CH2COR5; R5 represents hydroxy, optionally hydroxylated alkoxy, amino or alkylamido; R2 represents ZYR6; Z represents a bond, or a C1-3 alkylene or oxoalkylene group optionally substituted by R7; Y represents a bond, an oxygen atom or NR6; R6 is a hydrogen atom, COOR8, an alkyl, alkenyl, cycloalkyl, aryl or aralkyl group optionally substituted by one or more selected from COOR8, CONR82, NR82, OR8, ═NR8, ═O, OP(O)(OR8)R7 and OSO3M; R7 is hydroxy, an optionally hydroxylated, optionally alkoxylated alkyl or aminoalkyl group; R8 is a hydrogen atom or an optionally hydroxylated, optionally alkoxylated alkyl group; M is a hydrogen atom or one equivalent of a physiologically tolerable cation; R3 represents C1-8 alkylene, 1,2-cykloalkylene, or 1,2-arylene, optionally substituted with R7; and R4 represents hydrogen or C1-3 alkyl.

摘要翻译： 式I化合物或其盐用于治疗癌症，其中X表示CH或N; R1表示氢或-CH2COR5; R5表示羟基，任选羟基化的烷氧基，氨基或烷基酰氨基; R2表示ZYR6; Z表示键或任选被R 7取代的C 1-3亚烷基或氧代亚烷基; Y表示键，氧原子或NR 6; R6是氢原子，COOR8，烷基，烯基，环烷基，芳基或芳烷基，任选被一个或多个选自COOR8，CONR82，NR82，OR8，... NR8，= O，OP（O）（OR8）R7和 OSO3M; R7是羟基，任选羟基化，任选烷氧基化的烷基或氨基烷基; R8是氢原子或任选羟基化，任选烷氧基化的烷基; M是氢原子或1当量的生理上可耐受的阳离子; R 3表示任选被R 7取代的C 1-8亚烷基，1,2-亚环烷基或1,2-亚芳基; 并且R 4表示氢或C 1-3烷基。

公开(公告)号：US5049185A

公开(公告)日：1991-09-17

申请号：US469403

申请日：1990-05-08

申请人： Rolf Andersson

发明人： Rolf Andersson

IPC分类号： C21D1/74 ,  C21D1/76 ,  F27D3/16

CPC分类号： F27D3/16 ,  C21D1/74 ,  C21D1/76

摘要： The disclosure relates to a method for supplying, with a lance (11), a liquid to a heat treatment oven, the liquid being vaporized by the oven heat and being introduced into the oven with the aid of a carrier gas, and a lance (11) for carrying the method into effect.According to the method, the liquid is, with a carrier gas, atomized in an end of the lance (11) facing away from the interior of the oven, the atomized liquid and the carrier gas being supplied to a vaporization chamber (12) with an outlet aperture (14) directed towards the interior of the oven, in which chamber (12) the atomized liquid is vaporized by the oven heat during simultaneous cooling of the chamber (12), and the thus formed vapor and carrier gas are caused to depart from the vaporization chamber (12) of the lance (11) through the aperture designed as a nozzle (22).The lance (11) includes a vaporization chamber (12) with an inlet (13) for the liquid and the carrier gas in one end of the lance (12), and an outlet (14) in the other end of the chamber (12), and a liquid atomizing nozzle (15) in the inlet (13) of the chamber (12).

摘要翻译： PCT No.PCT / SE88 / 00490 Sec。 371日期1990年5月8日 102（e）日期1990年5月8日PCT提交1988年9月22日PCT公布。 出版物WO89 / 02937 日本1989年4月6日。本公开涉及一种用于将喷枪（11），液体供应到热处理炉的方法，所述液体被烘箱加热蒸发并借助于 载体气体和用于使该方法生效的喷枪（11）。 根据该方法，液体与载气一起雾化在喷枪（11）的远离烘箱内部的一端，雾化的液体和载气被提供到蒸发室（12） 指向烤箱内部的出口孔（14），在室（12）中，雾化的液体在室（12）的同时冷却期间通过烘箱加热而蒸发，并且使由此形成的蒸汽和载气被引导到 通过设计为喷嘴（22）的孔离开喷枪（11）的蒸发室（12）。 喷枪（11）包括具有用于液体的入口（13）和喷枪（12）的一端中的载气的蒸发室（12），以及在室（12）的另一端的出口（14） ）和在腔室（12）的入口（13）中的液体雾化喷嘴（15）。

公开(公告)号：US20070125401A1

公开(公告)日：2007-06-07

申请号：US10579374

申请日：2004-11-26

申请人： Peter Nord ,  Rolf Andersson

发明人： Peter Nord ,  Rolf Andersson

IPC分类号： B08B7/00 ,  B08B9/00

CPC分类号： C25C7/08

摘要： The invention relates to an equipment for removing deposits accumulated in electrolytic refining on the surface of an electrode, such as a cathode, said equipment including at least one element for stripping the deposits and at least one element for controlling the stripping element; said equipment includes at least one stripping element that is turnably movable in the vertical direction of the cathode, and the cathode can be bent owing to the contact with said stripping element. The invention also relates to a method realized by said equipment.

摘要翻译： 本发明涉及一种用于去除在诸如阴极的电极的表面上积聚在电解精炼中的沉积物的设备，所述设备包括用于剥离沉积物的至少一个元件和用于控制剥离元件的至少一个元件; 所述设备包括可在阴极的垂直方向上可转动地移动的至少一个剥离元件，并且阴极可由于与所述剥离元件的接触而弯曲。 本发明还涉及由所述设备实现的方法。